Kiniksa Pharmaceuticals International, plc Quarterly Common Stock, Shares Authorized from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Common Stock, Shares Authorized history and growth rate from Q4 2017 to Q4 2023.
  • Kiniksa Pharmaceuticals International, plc Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 200M 0 0% Dec 31, 2023 10-K 2024-02-28
Q4 2022 200M 0 0% Dec 31, 2022 10-K 2024-02-28
Q4 2021 200M 0 0% Dec 31, 2021 10-K 2023-03-02
Q4 2020 200M Dec 31, 2020 10-K 2022-02-24
Q2 2018 200M May 31, 2018 10-K 2021-02-25
Q1 2018 44.7M Feb 28, 2018 10-K 2021-02-25
Q4 2017 43.9M Dec 31, 2017 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.